ArticleFrontiers in pharmacology2023

Spirometric and anthropometric improvements in response to elexacaftor/tezacaftor/ivacaftor depending on age and lung disease severity.

Katharina Schütz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.